Features of rectal treatment of inflammatory bowel diseases
The article provides information on local inflammatory bowel diseases therapy, the peculiarities of the use of various rectal forms of anti-inflammatory drugs. The basic drug for the treatment of patients with inflammatory bowel diseases is 5-ASA, used both topically or orally, and in combination, i...
Saved in:
| Main Authors: | D. V. Egorov, Yu. A. Lazareva, E. S. Ivanyuk, P V. Seliverstov, Yu. A. Kravchuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2023-07-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of approaches to the treatment of mild to moderate ulcerative colitis
by: S. S. Belous, et al.
Published: (2021-09-01) -
Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01) -
Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine
by: E. V. Smirnova, et al.
Published: (2022-02-01) -
Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01) -
Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis
by: G. N. Yankinа, et al.
Published: (2019-10-01)